About this trial
The BloodTrackR Usability and Concordance Study (BUCS) is evaluating a novel home-based blood collection device and companion mobile application for people with rheumatoid arthritis. Participants will use the BloodTrackR device to collect a finger-prick blood sample at home and complete symptom assessments through the app.
The study will assess how easy the device and app are to use, whether participants can successfully collect high-quality blood samples outside of a healthcare setting, and how closely the results compare with standard venous blood samples collected by a phlebotomist. Findings will help determine the potential of BloodTrackR to support remote monitoring and reduce reliance on NHS phlebotomy services.
Eligibility criteria
Qualifiers
Individuals living with rheumatoid arthritis, who attend community groups or rheumatoid arthritis charity groups
Aged 18 years or older
Able to understand written and spoken English
Individuals who have the capacity to consent
Disqualifiers
Participants <18years
Participants taking antibiotics/antivirals
No access to WiFi or a smartphone/tablet
Trial design
Treatments tested in this trial
- BloodTrackR - Home Blood Collection Platform
Treatment groups
Sponsors and collaborators
University of Ulster
Lead sponsor
National Institute for Health Research, United Kingdom
Collaborator